Subscribe to Newsletter

Standards & Regulation

Manufacture Ingredients

Moving Away From “Quality by Fear”: Part I

| Stephanie Vine

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

Discovery & Development Standards & Regulation

Who’s the Coolest?

| Angus Stewart

A best practice competition developed to encourage labs to pursue more efficient cold storage is now on for 2022.

Business & Regulation Supply Chain

The Value of Dogged Determination

| Banks Bourne

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

Business & Regulation Business Practice

Teva Takes Hit in New York Opioid Case

| Stephanie Vine

After other defendants in the case settle, Teva is left to face the music in New York alone.

Business & Regulation Biosimilars

ICER Report Exposes Humira Price Hikes

| Angus Stewart

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.

Business & Regulation Advanced Medicine

2021 in Review: Our Best Videos

| Angus Stewart

Panels, thought leaders, and spicy opinions! Here’s a roundup of our best video content of 2021.

Business & Regulation Digital Technologies

Why We Need Patient-Centric Pharmacovigilance

| Saba Darvesh

Can digital approaches help improve pharmacovigilance practices?

Business & Regulation Standards & Regulation

The Sacred Texts

| Sue Batchelor

New ICH guideline revisions are imminent. Sue Batchelor of Cmed shares her thoughts on how sponsors and CROs can prepare themselves.

Business & Regulation Technology and Equipment

FDA Authorizes VR for Pain Reduction

| Stephanie Vine

AppliedVR gets FDA OK to market virtual reality system for chronic pain.

Business & Regulation Standards & Regulation

Will it Really Be Built Back Better?

| Stephanie Vine

A quick look at reactions across the US to Biden’s Build Back Better bill.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register